Links to protocol summaries of current & upcoming clinical trials at the Case site February 2020 5359: Latitude, a phase III, randomized, cross-over study to evaluate long-acting injectable antiretroviral therapy for people living with HIV who have not been adherent to their antiretroviral therapy in pill form. Latitude A5359 Provider […]
For Doctors
Vaccine-Induced SeroPositivity (VISP) The CWRU/UH AIDS Clinical Trials conducts HIV prevention vaccine trials in the Greater Cleveland area. The elicitation of antibodies to HIV by the vaccines can cause the risk of a false HIV diagnosis through standard HIV antibody testing. Please feel free to contact the Unit with any […]
Vaccine-Induced SeroPositivity (VISP)
Since its establishment in 1987, thousands of people living with HIV have participated in clinical trials at the Case ACTU. Their participation led directly to the development of effective and better treatments for HIV infection. Many of the clinical trials offered at the Case ACTU are through its affiliation with […]
Clinical Trials
Northeast Ohio AIDS Treating Physicians presents thePost-CROI Update Dinnerfor researchers, physicians, nurses and other healthcare professionals Thursday, April 16, 2020Reception 5:30pmDinner/presentations 6:15pm Glidden House Inn 1901 Ford DriveCleveland, Ohio 44106 Speakers: Christopher Longenecker, MD Associate Professor of Medicine, Case Western Reserve UniversityHarrington Heart & Vascular Institute, University Hospitals Cleveland Medical […]